Non-small Cell Lung Cancer : News

Healthline's Premium Tools

Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Washington, Nov 18 : Canadian researchers claim to have found an answer to why some former smokers develop lung cancer, while others don't - despite similar lifestyle changes.
Source:Newkerala.com
Date:November 18, 2008
... Taxotere and Docetaxel Winthrop were expected to be used for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress HER2 in the following combinations: in combination (given simultaneously) with trastuzumab ...
Source:Drugs.com
Date:November 18, 2008
Main Category: Lung Cancer Also Included In: Respiratory / Asthma ; Cancer / Oncology Article Date: 18 Nov 2008 - 3:00 PST A new Australian study has found that extending the use of chemotherapy in patients ...
Source:Medical News Today
Date:November 18, 2008
... SA (PAR: 12057) of the latter's decision to withdraw its application for an extension of indication for its cancer drugs Taxotere and Docetaxel Winthrop. The company stated that the withdrawal is based on the Committee for Medicinal Products for ...
Source:M2.com
Date:November 18, 2008
LONDON and CAMBRIDGE, MA-- - Cancer drug developer Antisoma plc holds its AGM today and provides an update on its key pipeline products and other corporate developments.
Source:Market Wire
Date:November 17, 2008
jbhiatt dermpaper Abstract BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation. Recently, we have identified activating BRAF mutations in 66% of melanomas and a smaller percentage of ...
Source:CiteULike
Date:November 17, 2008
Country legend Merle Haggard is resting comfortably at his home in Bakersfield, Calif., following recent surgery to have a malignant tumor removed from his lung.
Source:Country Weekly
Date:November 17, 2008
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab and cetuximab , is safe and may improve survival for patients with advanced lung cancer, according to a ...
Source:Medical News
Date:November 17, 2008
Lung Cancer Genetics Different in Black Patients, Case Western Reserve University , University of Colorado And Instituto Clinico Humanitas IRCCS Study 11/17/2008 ScienceDaily a ' The tumors of African-American ...
Source:BioSpace
Date:November 17, 2008
The combination of traditional chemotherapy agents with targeted therapies called monoclonal antibodies showed no safety concerns and improved survival in patients with advanced non-small cell lung cancer ...
Source:Medical News
Date:November 17, 2008
First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef Main Category: Lung Cancer Also Included In: Respiratory / Asthma ; Cancer / Oncology ; Clinical Trials / Drug ...
Source:Medical News Today
Date:November 17, 2008
... (Iressa; AstraZeneca, Mississisauga, Ontario, Canada). Report of a Case A 70-year-old woman with stage IV non-small cell lung cancer was evaluated regarding a 2-year history of scalp erythema and crusting that progressed to scarring alopecia (Figure ...
Source:Archives General Psychiatry
Date:November 17, 2008
Advertisement
Back to Top